Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-(-)-pantoprazole sodium injection versus pantoprazole sodium injection for peptic ulcer bleeding
ChiCTR1800018598Phase 2Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of pantoprazole in Peptic ulcer disease (PUD) and upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Effective hemostasis rate at 72 hours after medication. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer disease (PUD)upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on ChiCTR1800018598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018598.